Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
News|Articles|May 1, 2003
Pharmaceutical Technology Europe
- Pharmaceutical Technology Europe-05-01-2003
- Volume 15
- Issue 5
Drug safety in the limelight
Author(s)Jill Wechsler
Regular update from Washington.
Advertisement
The US Food and Drug Administration (FDA) is proposing that barcodes be used on drug packages, and that new error reporting standards should be introduced as part of the campaign to reduce medication errors.
This article is currently available in printed form only.
To ensure access to all articles from every issue of Pharmaceutical Technology Europe
Articles in this issue
over 23 years ago
The New Tabletting Facilityover 23 years ago
Nobler in the Mind? The Dilemma for European Researchover 23 years ago
The Death of the Drug Dossierover 23 years ago
Qualification of a Chromotographic Columnover 23 years ago
21 CFR Part 11: The New Draft GuidanceAdvertisement
Related to this article
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
In this episode of Pharma Fundamentals, Dr. Aleksandra Zuraw, senior veterinary pathologist at Charles River, provides an introduction to the use of digital pathology in drug development.
The agency issued a direct final rule that supports the use of innovative testing methods to limit the use of animals and maintain existing safety standards.
The FDA approves Inluriyo-Verzenio combo for ESR1-mutated breast cancer; EMBER-3 data double PFS, with supply chain and diagnostics implications for manufacturers.
This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
On PharmTech.com this week, coverage of upcoming events continued, experts continued to discuss the use of AI in pharma, and validation in oral solid dosage product production was emphasized.
Ronald Piervincenzi, USP, urges drugmakers and purchasers to act on supply chain resilience to curb drug shortages and shape better policy.
Advertisement
Advertisement